STAGE III LUNG CANCER AJCC V8
Clinical trials for STAGE III LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made cancer vaccine shows promise in early trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study tests a personalized vaccine made from unique markers on a patient's own tumor. The goal is to help the immune system fight advanced breast cancer, melanoma, and lung cancer that has not responded to other treatments. About 25 adults with these cancers will…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 15:02 UTC
-
New hope for stubborn lung cancer: combo therapy targets resistant tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug (GT103) to an existing immunotherapy (pembrolizumab) can help people with a specific type of advanced lung cancer (STK11 mutant NSCLC) that has stopped responding to treatment. About 28 adults whose cancer has spread will recei…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system attack cancer more effectively. …
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
Common painkiller could boost immunotherapy in lung cancer
Disease control Recruiting nowThis study tests whether adding diclofenac, a common anti-inflammatory painkiller, can help control tumor growth in people with advanced non-small cell lung cancer whose disease is starting to worsen while on immunotherapy alone. About 20 adults with stage III or IV lung cancer w…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC